The FTC forced Amazon into a $2.5 billion settlement over Prime signups and cancellations. Millions of users could see ...
By shifting from a passive web presence to an active, editorial-driven approach, SaaS leaders can turn their websites into ...
The investing information provided on this page is for educational purposes only. NerdWallet, Inc. does not offer advisory or ...
BERRIEN COUNTY, Mich. -- The Michigan Department of Transportation is encouraging a new Berrien County Transportation Authority to replace the struggling Twin Cities Area Transportation Authority ...
Anchor and Correspondent, "CBS News 24/7" Lilia Luciano is an award-winning journalist and CBS News 24/7 anchor and correspondent based in New York City. Luciano is the recipient of multiple ...
PITTSBURGH — Carnegie Mellon University is taking steps to address controversial messages painted on its iconic Fence. In a letter, CMU President Farnam Jahanian announced the university will form a ...
HOUSTON — The morning after Yankees players felt like a series balls-and-strikes calls contributed to Wednesday night’s loss to the Astros, manager Aaron Boone “had some conversations” on Thursday ...
Julian Nagelsmann admits Germany's self-image is crumbling after suffering back-to-back defeats Trailer full of guns and ammo bound for Mexico stopped at border Epstein Files Drop Shake Up Trump Admin ...
A Japanese research team successfully harnessed E. coli to produce PDCA, a strong, biodegradable plastic alternative. Their method avoids toxic byproducts and achieves record production levels, ...
Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results